Back to Search Start Over

VEXAS syndrome following COVID‐19 mRNA vaccination.

Authors :
Skowron, François
Klepfisch, Lucas
Guillaume, Laurent
Godeneche, Janique
Facile, Anthony
Gombert, Martin
Pechuzal, Suzann
Perrot, Jean‐Luc
Source :
Journal of the European Academy of Dermatology & Venereology; Aug2023, Vol. 37 Issue 8, pe955-e958, 4p
Publication Year :
2023

Abstract

Finally, we diagnosed a VEXAS syndrome following COVID-19 vaccination. VEXAS syndrome following COVID-19 mRNA vaccination Dear Editor, VEXAS syndrome (vacuoles in myeloid progenitors, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory manifestations and somatic) is a recently described adult-onset autoinflammatory disease.[1] A 76-year-old man was vaccinated against SARS-CoV-2 with the Tozinameran/BNT162b2 (Pfizer/BioNTech) on 1 April 2021. [Extracted from the article]

Details

Language :
English
ISSN :
09269959
Volume :
37
Issue :
8
Database :
Complementary Index
Journal :
Journal of the European Academy of Dermatology & Venereology
Publication Type :
Academic Journal
Accession number :
166735083
Full Text :
https://doi.org/10.1111/jdv.19104